The initial doses in the osteoarthritis trial were thought to be sub-pharmacologically active or inactive.

“so we had 6 dose levels and so they were marched up from essentially a group of a series of doses three of them which we based on some modeling we did and in cell culture we thought would be sub pharmacologically active doses so we thought they'd be semi and active or inactive entirely”